Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Statistics

Total Valuation

UNCY has a market cap or net worth of $127.23 million. The enterprise value is $80.07 million.

Market Cap	127.23M
Enterprise Value	80.07M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

UNCY has 21.49 million shares outstanding. The number of shares has increased by 167.35% in one year.

Current Share Class	21.49M
Shares Outstanding	21.49M
Shares Change (YoY)	+167.35%
Shares Change (QoQ)	+46.85%
Owned by Insiders (%)	2.93%
Owned by Institutions (%)	16.90%
Float	17.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	1.63
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.21
P/TBV Ratio	3.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.01.

Current Ratio	3.83
Quick Ratio	3.25
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-493.03

Financial Efficiency

Return on equity (ROE) is -102.29% and return on invested capital (ROIC) is -59.40%.

Return on Equity (ROE)	-102.29%
Return on Assets (ROA)	-44.23%
Return on Invested Capital (ROIC)	-59.40%
Return on Capital Employed (ROCE)	-84.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.70% in the last 52 weeks. The beta is 1.86, so UNCY's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	+28.70%
50-Day Moving Average	4.59
200-Day Moving Average	5.30
Relative Strength Index (RSI)	74.15
Average Volume (20 Days)	558,529

Short Selling Information

The latest short interest is 1.21 million, so 5.63% of the outstanding shares have been sold short.

Short Interest	1.21M
Short Previous Month	1.01M
Short % of Shares Out	5.63%
Short % of Float	6.78%
Short Ratio (days to cover)	2.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.55M
Pretax Income	-33.41M
Net Income	-33.41M
EBITDA	-31.52M
EBIT	-31.55M
Earnings Per Share (EPS)	-$2.54

Balance Sheet

The company has $42.70 million in cash and $265,000 in debt, giving a net cash position of $42.43 million or $1.97 per share.

Cash & Cash Equivalents	42.70M
Total Debt	265,000
Net Cash	42.43M
Net Cash Per Share	$1.97
Equity (Book Value)	37.48M
Book Value Per Share	1.80
Working Capital	37.16M

Cash Flow

In the last 12 months, operating cash flow was -$29.83 million and capital expenditures -$46,000, giving a free cash flow of -$29.88 million.

Operating Cash Flow	-29.83M
Capital Expenditures	-46,000
Free Cash Flow	-29.88M
FCF Per Share	-$1.39

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-167.35%
Shareholder Yield	-167.35%
Earnings Yield	-27.27%
FCF Yield	-24.39%

Analyst Forecast

The average price target for UNCY is $41.60, which is 602.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.60
Price Target Difference	602.70%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 20, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 20, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2